Sur180 Therapeutics, Inc.

McAllen, TX

UEI
FJ5GRNYE15X1
CAGE
93GY1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

SBA certifications
Women-Owned Small Business
· Current
Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
1444 Providence Ave, McAllen, TX 78504, USA
Website
sur180therapeutics.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Quick answers

Is Sur180 Therapeutics, Inc. registered in SAM.gov?

Yes. Sur180 Therapeutics, Inc.'s SAM.gov registration is active through February 3, 2027.

Which SBA certifications does Sur180 Therapeutics, Inc. hold?

Sur180 Therapeutics, Inc. holds Women-Owned Small Business certification from the SBA.

What is Sur180 Therapeutics, Inc.'s most recent federal award?

Sur180 Therapeutics, Inc.'s most recent federal grant award is Phase II- repurposing CRH antagonists for the treatment of endometriosis (R44HD109055), from National Institute of Child Health and Human Development (NIH), on June 1, 2023.

On GovTribe

See Sur180 Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors